Breakthrough solutions to improve health and advance science.
Luminex Corporation (NASDAQ: LMNX) was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex develops, manufactures and markets innovative biological testing technologies with applications throughout the diagnostic and life science industries. The company’s open-architecture xMAP® and xTAG® Technologies enable large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately. Systems using xMAP technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer.
Luminex transforms the way our customers perform biological testing.
We pioneer comprehensive yet simple solutions to improve outcomes and reduce overall costs.
Every day we work to enhance the health, safety and quality of life for all.
Ensure partners, end-user customers and patients are always our highest priority
Develop and maintain a culture that values and rewards integrity, execution, teamwork, creativity and communication
Deliver best-in-class innovative solutions through the highest quality products and services that address unmet needs of our customers
Build long term value for our shareholders and employees by pursuing sustainable growth, continually improving the efficiency of our operations and maximizing return on investment